Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TerumoTSE:4543 +0.04%90 Median PS Value is 円3,266.06 as of Aug. 26, 2026. GuruFocus rates TSE:4543 with a GF Score™ of 90/100 and a GF Value™ of 円3,191.25 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 339 Medical Devices & Instruments companies, Terumo ranks worse than 58.41% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Terumo's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was 円802.354. Terumo's 10-Year median PS Ratio is 4.0706. Therefore, the Median PS Value for today is 円3,266.06.
As of today (2026-08-26), Terumo's share price is 円2596.50. Terumo's Median PS Value is 円3,266.06. Therefore, Terumo's Price to Median PS Value for today is 0.79.
The historical rank and industry rank for Terumo's Median PS Value or its related term are showing as below:
TSE:4543'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.67 Med: 1.21 Max: 1.88
Current: 0.79
During the past 13 years, the highest Price to Median PS Value of Terumo was 1.88. The lowest was 0.67. And the median was 1.21.
TSE:4543's Price-to-Median-PS-Value is ranked worse than 58.41% of 339
companies
in the Medical Devices & Instruments industry
Industry Median: 0.72
vs TSE:4543: 0.79
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Terumo's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2596.50
/
3,266.06
=
0.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo Median PS Value Related Terms
Terumo Median PS Value Historical Data
* Premium members only.
The historical data trend for Terumo's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4543 vs ISRG, BDX, MDLN: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, Terumo's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terumo Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Terumo's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 4.0706.
Terumo's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円802.354.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo (TSE:4543) has a Median PS Value of 円3,266.06 as of Aug. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Terumo and its competitors. According to the industry distribution chart, Terumo ranks #198 out of 339 companies in the Medical Devices & Instruments industry, placing it in the top 58.4%.
Is Terumo's Median PS Value too high?
Terumo's current Median PS Value is 円3,266.06. Based on the distribution chart, Terumo ranks #198 out of 339 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Terumo has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Median PS Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Terumo ranks #198 out of 339 companies for Median PS Value. This places Terumo in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.72, based on 339 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Terumo and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terumo's current Median PS Value is 円3,266.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TSE:4543) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,191.25, compared to a current price of 円2,596.50 — trading 18.6% below its estimated fair value. The current Median PS Value is 円3,266.06. Terumo's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Terumo (TSE:4543), the current Median PS Value is 円3,266.06 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terumo (TSE:4543) Overvalued in 2026?
Based on GuruFocus' analysis, Terumo stock appears to be undervalued.
The current stock price of 円2,596.50 is trading 18.6% below its estimated GF Value™ of 円3,191.25.
GuruFocus considers Terumo to be Modestly Undervalued.
Key valuation signals for TSE:4543:
Median PS Value: 円3,266.06
GF Value™: 円3,191.25 vs. price of 円2,596.50 (18.6% below fair value)
No single metric tells the full story. See the TSE:4543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
90GF Score
Get the complete analysis for TSE:4543
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4543 has been successfully added to your 
